Investor profile
- Type
- Venture Capital
- Headquarters
- Zaventem
- Aliases
- Droia, Droia Oncology Ventures, Droia Ventures
- Tracked investments
- 1
- Regions
- Global, Europe, North America
- Stages
- Seed, Series A, Series B, Growth
- Sectors
- Biotechnology, Artificial Intelligence
Recent related events
- Vaderis Therapeutics raises $152.0MAug 11, 2026